Evidence map›Paper›PMID 25268975›Full record

ArticlePloS one2014

Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer.

Kirtee D Wani, Brijesh S Kadu, Prakash Mansara, Preeti Gupta, Avinash V Deore, Rajeev C Chikate, Pankaj Poddar, Sanjay D Dhole, Ruchika Kaul-Ghanekar

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Comparative effects of parent and heated cinnamaldehyde on the function of human iPSC-derived cardiac myocytes.Toxicology in vitro : an international journal published in association with BIBRA · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kirtee D WaniCell and Translational Research Laboratory, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University Medical College Campus, Dhankawadi, Pune, Maharashtra, India.
Brijesh S KaduNanoscience Group, Department of Chemistry, Post-graduate and Research Center, MES Abasaheb Garware College, Pune, Maharashtra, India.
Prakash MansaraCell and Translational Research Laboratory, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University Medical College Campus, Dhankawadi, Pune, Maharashtra, India.
Preeti GuptaPhysical and Material Chemistry Division, CSIR-National Chemical Laboratory, Pune, Maharashtra, India.
Avinash V DeoreDepartment of Physics, University of Pune, Pune, Maharashtra, India.
Rajeev C ChikateNanoscience Group, Department of Chemistry, Post-graduate and Research Center, MES Abasaheb Garware College, Pune, Maharashtra, India.
Pankaj PoddarPhysical and Material Chemistry Division, CSIR-National Chemical Laboratory, Pune, Maharashtra, India.
Sanjay D DholeDepartment of Physics, University of Pune, Pune, Maharashtra, India.
Ruchika Kaul-GhanekarCell and Translational Research Laboratory, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University Medical College Campus, Dhankawadi, Pune, Maharashtra, India.
Bharati Vidyapeeth Deemed University · INAbasaheb Garware College · INNational Chemical Laboratory · INSavitribai Phule Pune University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cinnamaldehyde, the bioactive component of the spice cinnamon, and its derivatives have been shown to possess anti-cancer activity against various cancer cell lines. However, its hydrophobic nature invites attention for efficient drug delivery systems that would enhance the bioavailability of cinnamaldehyde without affecting its bioactivity. Here, we report the synthesis of stable aqueous suspension of cinnamaldehyde tagged Fe3O4 nanoparticles capped with glycine and pluronic polymer (CPGF NPs) for their potential application in drug delivery and hyperthermia in breast cancer. The monodispersed superparamagnetic NPs had an average particulate size of ∼ 20 nm. TGA data revealed the drug payload of ∼ 18%. Compared to the free cinnamaldehyde, CPGF NPs reduced the viability of breast cancer cell lines, MCF7 and MDAMB231, at lower doses of cinnamaldehyde suggesting its increased bioavailability and in turn its therapeutic efficacy in the cells. Interestingly, the NPs were non-toxic to the non-cancerous HEK293 and MCF10A cell lines compared to the free cinnamaldehyde. The novelty of CPGF nanoparticulate system was that it could induce cytotoxicity in both ER/PR positive/Her2 negative (MCF7) and ER/PR negative/Her2 negative (MDAMB231) breast cancer cells, the latter being insensitive to most of the chemotherapeutic drugs. The NPs decreased the growth of the breast cancer cells in a dose-dependent manner and altered their migration through reduction in MMP-2 expression. CPGF NPs also decreased the expression of VEGF, an important oncomarker of tumor angiogenesis. They induced apoptosis in breast cancer cells through loss of mitochondrial membrane potential and activation of caspase-3. Interestingly, upon exposure to the radiofrequency waves, the NPs heated up to 41.6 °C within 1 min, suggesting their promise as a magnetic hyperthermia agent. All these findings indicate that CPGF NPs prove to be potential nano-chemotherapeutic agents in breast cancer.

Indexed as

AcroleinAntineoplastic AgentsBiocompatible MaterialsBreast NeoplasmsCell MovementCell ProliferationCell SurvivalDrug CarriersDrug Screening Assays, AntitumorDrug StabilityFemaleGlycineHEK293 CellsHumansHyperthermia, InducedInhibitory Concentration 50AcroleinAntineoplastic AgentsBiocompatible MaterialscinnamaldehydeDrug CarriersGlycineMagnetite NanoparticlesPoloxamer

Identifiers

PMID25268975
PMCPMC4182032
OpenAlexW1983515979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.